Pricing Log in Create free account

Aquestive Therapeutics, Inc. (AQST) vs Evotec AG (EVO)

Aquestive Therapeutics, Inc. and Evotec AG are both Drug Manufacturers Specialty & Generic companies. Aquestive Therapeutics, Inc. and Evotec AG are of similar size ($509.6M and $504.4M). Aquestive Therapeutics, Inc. grew revenue faster over the last twelve months: 22.6% against 2.15%. Evotec AG has the higher net margin (−26.2% vs −144.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Evotec AG leads on 9 and Aquestive Therapeutics, Inc. on 7.

Valuation

Metric AQST EVO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 8.74 0.57 2.11
P/B n/m 0.63 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales 7.85 0.58 2.73
Earnings yield (17.20%) (46.23%) (4.38%)
Free cash flow yield (9.73%) (40.86%) 0.00%

Profitability

Metric AQST EVO Drug Manufacturers Specialty & Generic median
Gross margin 67.04% 11.42% 53.94%
Operating margin (97.52%) (21.35%) 0.00%
Net margin (144.63%) (26.20%) 0.00%
Free cash flow margin (84.95%) 0.00% 0.00%
Return on equity 121.12% 0.00% (0.40%)
Return on assets (69.29%) 0.00% (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AQST EVO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 22.56% 2.15% 10.01%
EPS growth (last fiscal year) (52.94%) 44.89% 49.06%
Revenue growth, 5-year CAGR (0.58%) 9.28% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AQST EVO Drug Manufacturers Specialty & Generic median
Debt to equity (0.90) 0.72 0.05
Current ratio 7.19 2.33 2.31
Net debt to EBITDA 1.57 (0.64) 0.97

Dividend

Metric AQST EVO Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric AQST EVO Drug Manufacturers Specialty & Generic median
Market cap 509.58m 504.36m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack